IP Library Granted Patent US 12,491,111
Granted Patent B2
US 12,491,111 · App. 18/329,653 · Granted Dec 9, 2025

Medical instrument for in vivo heat source

Inventor: Anand Deo (Mendota Heights, MN)
A61F7/12H01L21/324H01L21/67103H01L21/67248H05B1/023H05B6/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,491,111
App. No.
18/329,653
Granted
Dec 9, 2025
Kind
B2
Abstract

A biocompatible medical device can be at least partially implantable into a living human or animal subject to provide active treatment of biofilm that can occur use within the subject. The medical device can include a catheter, including an interior conduit capable of permitting fluid flow. A heating device can be located on a portion of the catheter to be located within the subject, the heating device including at least a pair of electrodes having a variable spacing therebetween, the variable spacing specified to allow heat to be generated using a time-varying electromagnetic input signal providing a variable frequency to control a variable location along the electrodes at which heat is generated, such as can provide a virtual matrix of local heat sources.

Claims (32)

1 . A medical device that is at least partially insertable or implantable into a living human or animal subject, the medical device comprising:

a body, sized and shaped to include a biocompatible portion that is configured to be insertable or implantable into the subject, the body including:

an electrical conductor, connected or coupled to receive an AC electromagnetic input signal;

at least one of a semiconductor, a lossy dielectric, a thin-film metal, or a crystalline substrate, arranged with respect to the electrical conductor to use the AC electromagnetic input signal varied to a specified frequency to select a sensor location in response thereto; and

wherein the sensor is included in a plurality of sensors that are integrated with corresponding heat sources, and wherein the AC electromagnetic input signal is at least one of scanned or swept across different frequencies for providing frequency-addressing of the sensor.

2 . The medical device of claim 1 , wherein the at least one of a semiconductor, a lossy dielectric, a thin-film metal, or a crystalline substrate includes an active substrate, arranged with respect to the electrical conductor to use the AC electromagnetic input signal varied to a specified frequency to select a heat source location of a local heat source in the active substrate in response to the same AC electromagnetic input signal being at the specified frequency and also to generate heat in the active substrate using the local heat source at the selected heat source location that is selected using the frequency of the same AC electromagnetic input signal.

3 . The medical device of claim 1 , wherein the sensor includes a temperature sensor that is electrically connected to the heat source.

4 . The medical device of claim 1 , wherein the sensor is configured to be selectable using an addressing frequency for addressing a planar resonator.

5 . The medical device of claim 4 , wherein the planar resonator includes a capacitive coupling to a main line.

6 . The medical device of claim 4 , wherein the planar resonator includes an electrically conductive coupling to a main line.

7 . The medical device of claim 1 , wherein the electrical conductor includes a pair of electrodes having a spacing therebetween, the spacing specified to allow heat to be generated using the AC electromagnetic input signal providing a variable frequency to control a variable location along the electrodes at which heat is generated in the substrate.

8 . A medical device that is at least partially insertable or implantable into a living human or animal subject, the medical device comprising:

a body, sized and shaped to include a biocompatible portion that is configured to be insertable or implantable into the subject, the body including:

an electrical conductor, connected or coupled to receive an AC electromagnetic input signal; and

at least one of a semiconductor, a lossy dielectric, thin-film metal, or a crystalline substrate, arranged with respect to the electrical conductor to use the AC electromagnetic input signal varied to a specified frequency to select a sensor location in response thereto, wherein the sensor includes at least one of a pressure sensor, an optical conductor, or a radiofrequency identification (RFID) module.

9 . The medical device of claim 8 , wherein the sensor includes an optical conductor.

10 . The medical device of claim 8 , wherein the sensor includes a radiofrequency identification (RFID) module.

11 . The medical device of claim 8 , wherein the sensor includes a frequency-selective filter configured to permit frequency-selective addressing of the sensor.

12 . A medical device that is at least partially insertable or implantable into a living human or animal subject, the medical device comprising:

a body, sized and shaped to include a biocompatible portion that is configured to be insertable or implantable into the subject, the body including:

an electrical conductor, connected or coupled to receive an AC electromagnetic input signal; and

at least one of a semiconductor, a lossy dielectric, a thin-film metal, or a crystalline substrate, arranged with respect to the electrical conductor to use the AC electromagnetic input signal varied to a specified frequency to select a transducer location of a transducer in response thereto, wherein the transducer includes at least one of a mechanical output transducer, a piezoelectric transducer, or a fluid flow sensor.

13 . The device of claim 12 , wherein the transducer includes a sensor.

14 . The device of claim 12 , wherein the transducer includes a heat source, and wherein the at least one of a semiconductor, a lossy dielectric, a thin-film metal, or a crystalline substrate includes an active substrate, arranged with respect to the electrical conductor to use the AC electromagnetic input signal varied to a specified frequency to select a heat source location of a local heat source in the active substrate in response to the same AC electromagnetic input signal being at the specified frequency and also to generate heat in the active substrate using the local heat source at the selected heat source location that is selected using the frequency of the same AC electromagnetic input signal.

15 . The device of claim 12 , wherein the transducer includes a mechanical output transducer.

16 . The device of claim 12 , wherein the transducer includes a piezoelectric transducer.

17 . The device of claim 12 , wherein the transducer includes a fluid flow sensor.

18 . A medical device that is at least partially insertable or implantable into a living human or animal subject, the medical device comprising:

a body, sized and shaped to include a biocompatible portion that is configured to be insertable or implantable into the subject, the body including:

an electrical conductor, connected or coupled to receive an AC electromagnetic input signal;

at least one of a semiconductor, a lossy dielectric, a thin-film metal, or a crystalline active substrate, configured to generate heat at one or more transducer locations in the active substrate in response to the AC electromagnetic input signal, the active substrate arranged with respect to the electrical conductor to use the AC electromagnetic input signal varied to a specified frequency to select a transducer location in the active substrate in response thereto; and

wherein a temperature at the transducer location is used to control a parameter of the AC electromagnetic input signal to adjust, in response to the temperature at the transducer location, generating heat in the active substrate by a transducer including the active substrate at the transducer location.

Continuity (5)
Continuation 16666773 · Oct 29, 2019
Continuation 16027139 · Jul 3, 2018
Continuation In Part PCTUS2016069490 · Dec 30, 2016
Continuation 15165096 · May 26, 2016
Related Publication 20230390107A1 · Dec 7, 2023
References Cited (199)
US 3780255A · Boom · 1973 [cited by applicant]
US 4338575A · Hartemann · 1982 [cited by applicant]
US 4945912A · Langberg · 1990 [cited by applicant]
US 5037395A · Spencer · 1991 [cited by applicant]
US 5057105A · Malone et al. · 1991 [cited by applicant]
US 5191883A · Lennox et al. · 1993 [cited by applicant]
US 5257635A · Langberg · 1993 [cited by applicant]
US 5260020A · Wilk et al. · 1993 [cited by applicant]
US 5290490A · Nied et al. · 1994 [cited by applicant]
US 5498261A · Strul · 1996 [cited by applicant]
US 5810802A · Panescu et al. · 1998 [cited by applicant]
US 5891182A · Fleming · 1999 [cited by applicant]
US 6157804A · Richmond et al. · 2000 [cited by applicant]
US 6387052B1 · Quinn et al. · 2002 [cited by applicant]
US 6426277B1 · Bae et al. · 2002 [cited by applicant]
US 6443547B1 · Takahashi et al. · 2002 [cited by applicant]
US 6511851B1 · Payne et al. · 2003 [cited by applicant]
US 6537864B1 · Aya et al. · 2003 [cited by applicant]
US 6537927B1 · Son · 2003 [cited by applicant]
US 6825734B2 · Clark · 2004 [cited by applicant]
US 6901683B2 · Lyle et al. · 2005 [cited by applicant]
US 7133180B2 · Ilchenko et al. · 2006 [cited by applicant]
US 7160297B2 · Nesbitt · 2007 [cited by applicant]
US 7274262B2 · Ham et al. · 2007 [cited by applicant]
US 7317216B2 · Holm-kennedy · 2008 [cited by applicant]
US 7393501B2 · Zumeris et al. · 2008 [cited by applicant]
US 7429719B1 · Spetz · 2008 [cited by applicant]
US 7586381B2 · Rohde et al. · 2009 [cited by applicant]
US 7844345B2 · Boling · 2010 [cited by examiner]
US 8381601B2 · Stumpf · 2013 [cited by applicant]
US 8698570B2 · Afshari et al. · 2014 [cited by applicant]
US 8905772B2 · Rogers et al. · 2014 [cited by applicant]
US 8933416B2 · Arcand et al. · 2015 [cited by applicant]
US 9008793B1 · Cosman, Sr. et al. · 2015 [cited by applicant]
US 9156228B2 · Buehring et al. · 2015 [cited by applicant]
US 9362604B2 · Denis et al. · 2016 [cited by applicant]
US 9536758B1 · Deo · 2017 [cited by applicant]
US 9675402B2 · Yasunaga · 2017 [cited by applicant]
US 10326426B2 · Bhattacharjee · 2019 [cited by applicant]
US 10431478B2 · Deo · 2019 [cited by applicant]
US 10515831B2 · Deo · 2019 [cited by applicant]
US 10553462B2 · Deo · 2020 [cited by applicant]
US 11152232B2 · Deo · 2021 [cited by applicant]
US 11610791B2 · Deo · 2023 [cited by applicant]
US 11712368B2 · Deo · 2023 [cited by applicant]
US 11729869B2 · Deo · 2023 [cited by applicant]
US 12027386B2 · Deo · 2024 [cited by applicant]
US 12137509B2 · Deo · 2024 [cited by applicant]
US 20020065052A1 · Pande et al. · 2002 [cited by applicant]
US 20020120296A1 · Mech et al. · 2002 [cited by applicant]
US 20030164371A1 · Bergstrom et al. · 2003 [cited by applicant]
US 20030205571A1 · Flugstad et al. · 2003 [cited by applicant]
US 20050068116A1 · Ham et al. · 2005 [cited by applicant]
US 20050083785A1 · Shiokawa et al. · 2005 [cited by applicant]
US 20060071237A1 · Deboy et al. · 2006 [cited by applicant]
US 20070161263A1 · Meisner · 2007 [cited by applicant]
US 20070260239A1 · Podhajsky et al. · 2007 [cited by applicant]
US 20090054881A1 · Krespi · 2009 [cited by applicant]
US 20090071952A1 · Kuwabara · 2009 [cited by applicant]
US 20090131845A1 · Gurtner et al. · 2009 [cited by applicant]
US 20090131854A1 · DiCarlo et al. · 2009 [cited by applicant]
US 20090162954A1 · Griffin, Jr. et al. · 2009 [cited by applicant]
US 20090256649A1 · Taniguchi · 2009 [cited by applicant]
US 20100030210A1 · Paulus · 2010 [cited by applicant]
US 20100036375A1 · Regadas · 2010 [cited by applicant]
US 20100036405A1 · Giordano et al. · 2010 [cited by applicant]
US 20100191232A1 · Boveda · 2010 [cited by applicant]
US 20100217259A1 · Strauss · 2010 [cited by applicant]
US 20100249692A1 · Dacey, Jr. et al. · 2010 [cited by applicant]
US 20100286691A1 · Kerr et al. · 2010 [cited by applicant]
US 20110137390A1 · Hill · 2011 [cited by applicant]
US 20110152790A1 · Dacey, Jr. et al. · 2011 [cited by applicant]
US 20110226759A1 · Wander et al. · 2011 [cited by applicant]
US 20120029500A1 · Jenson · 2012 [cited by examiner]
US 20120152935A1 · Kitaizumi et al. · 2012 [cited by applicant]
US 20120259327A1 · Klimovitch · 2012 [cited by examiner]
US 20120261405A1 · Kurose et al. · 2012 [cited by applicant]
US 20120330393A1 · Janik et al. · 2012 [cited by applicant]
US 20130096595A1 · Myhr et al. · 2013 [cited by applicant]
US 20130282084A1 · Mathur et al. · 2013 [cited by applicant]
US 20140088674A1 · Bradley · 2014 [cited by applicant]
US 20140257272A1 · Clark et al. · 2014 [cited by applicant]
US 20150119877A1 · Jameson et al. · 2015 [cited by applicant]
US 20150289316A1 · Shimizu et al. · 2015 [cited by applicant]
US 20170258628A1 · Awasthi · 2017 [cited by applicant]
US 20180042667A1 · Pappone et al. · 2018 [cited by applicant]
US 20180323090A1 · Deo · 2018 [cited by applicant]
US 20190109024A1 · Deo · 2019 [cited by applicant]
US 20200013644A1 · Deo · 2020 [cited by applicant]
US 20200118846A1 · Deo · 2020 [cited by applicant]
US 20200135507A1 · Deo · 2020 [cited by applicant]
US 20200176283A1 · Deo · 2020 [cited by applicant]
US 20220108899A1 · Deo · 2022 [cited by applicant]
US 20230111595A1 · Deo · 2023 [cited by applicant]
US 20230181354A1 · Deo · 2023 [cited by applicant]
US 20240008148A1 · Deo et al. · 2024 [cited by applicant]
US 20240387204A1 · Deo · 2024 [cited by applicant]
CA 2993930A1 · 2017 [cited by applicant]
CN 106267534A · 2017 [cited by applicant]
EP 3113281A1 · 2017 [cited by applicant]
EP 3648693 · 2024 [cited by applicant]
EP 3466199 · 2024 [cited by applicant]
GB 1529941A · 1978 [cited by applicant]
WO WO9600039A1 · 1996 [cited by applicant]
WO WO2012153529A1 · 2012 [cited by applicant]
WO WO2016181397A1 · 2016 [cited by applicant]
WO WO2017204860A1 · 2017 [cited by applicant]
WO WO2019010238A1 · 2019 [cited by applicant]
WO WO2020010247A1 · 2020 [cited by applicant]
WO WO2023064873A1 · 2023 [cited by applicant]
“U.S. Appl. No. 15/165,096, Notice of Allowance mailed Aug. 31, 2016”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Corrected Notice of Allowability mailed Sep. 20, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Corrected Notice of Allowability mailed Oct. 29,19”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Examiner Interview Summary mailed Jun. 21, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Non Final Office Action mailed Mar. 22, 2019”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Non Final Office Action mailed Nov. 19, 2018”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Notice of Allowance mailed Jul. 29, 2019”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Response filed Dec. 10, 2018 to Non Final Office Action mailed Nov. 19, 2018”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/027,139, Response filed Jun. 20, 2019 to Non-Final Office Action mailed Mar. 22, 2019”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 16/200,120, Corrected Notice of Allowability mailed Aug. 26, 2019”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/200,120, Examiner Interview Summary mailed Apr. 11, 2019”, 3 pgs. [cited by applicant]
“U.S. Appl. No. 16/200,120, Notice of Allowance mailed May 22, 2019”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/200,120, Response filed Mar. 25, 2019 to Non-Final Office Action mailed Jan. 24, 2019”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 16/200,120, Supplemental Response filed Apr. 8, 2019 to Non-Final Office Action mailed Jan. 24, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/502,989, Corrected Notice of Allowability mailed Oct. 31, 2019”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/502,989, Notice of Allowance mailed Sep. 25, 2019”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/502,989, Preliminary Amendment filed Jul. 11, 2019”, 4 pgs. [cited by applicant]
“U.S. Appl. No. 16/548,809, Final Office Action mailed Aug. 24, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/548,809, Non Final Office Action mailed Mar. 3, 2022”, 16 pgs. [cited by applicant]
“U.S. Appl. No. 16/548,809, Notice of Allowance mailed Nov. 9, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/548,809, Preliminary Amendment filed Jan. 6, 2020”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 16/548,809, Response filed Jun. 3, 2022 to Non Final Office Action mailed Mar. 3, 2022”, 12 pgs. [cited by applicant]
“U.S. Appl. No. 16/548,809, Response filed Oct. 24, 2022 to Final Office Action mailed Aug. 24, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, 312 Amendment filed Jun. 6, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Final Office Action mailed Jun. 16, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Non Final Office Action mailed Feb. 16, 2022”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Non Final Office Action mailed Oct. 3, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Notice of Allowance mailed Mar. 7, 2023”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Preliminary Amendment filed Jan. 21, 2020”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, PTO Response to Rule 312 Communication mailed Jun. 28, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Response filed May 16, 2022 to Non Final Office Action mailed Feb. 16, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Response filed Aug. 16, 2022 to Final Office Action mailed Jun. 16, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/666,773, Response filed Dec. 29, 2022 to Non Final Office Action mailed Oct. 3, 2022”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/780,554, Corrected Notice of Allowability mailed Sep. 15, 2021”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/780,554, Final Office Action mailed Jan. 27, 2021”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/780,554, Non Final Office Action mailed Sep. 22, 2020”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/780,554, Notice of Allowance mailed Apr. 29, 2021”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/780,554, Response filed Apr. 13, 2021 to Final Office Action mailed Jan. 27, 2021”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/780,554, Response filed Dec. 15, 2020 to Non Final Office Action mailed Sep. 22, 2020”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 17/444,855, Non Final Office Action mailed Aug. 1, 2023”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 18/046,414, 312 Amendment filed Mar. 20, 2023”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 18/046,414, Corrected Notice of Allowability mailed Mar. 29, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/046,414, Corrected Notice of Allowability mailed Jun. 20, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/046,414, Notice of Allowance mailed Mar. 16, 2023”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/046,414, Response filed Feb. 15, 2023 to Restriction Requirement mailed Feb. 14, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/046,414, Restriction Requirement mailed Feb. 14, 2023”, 6 pgs. [cited by applicant]
“U.S. Appl. No. 18/164,087, Preliminary Amendment filed Jul. 28, 2023”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 18/334,703, Preliminary Amendment filed Sep. 5, 2023”, 8 pgs. [cited by applicant]
“European Application Serial No. 16903365.1, Communication Pursuant to Article 94(3) EPC mailed May 11, 2021”, 5 pgs. [cited by applicant]
“European Application Serial No. 16903365.1, Extended European Search Report mailed May 17, 2019”, 8 pgs. [cited by applicant]
“European Application Serial No. 18827857.6, Extended European Search Report mailed Jul. 13, 2020”, 6 pgs. [cited by applicant]
“European Application Serial No. 19830071.7, Extended European Search Report mailed Aug. 16, 2021”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2016/069490, International Preliminary Report on Patentability mailed Jul. 10, 2018”, 1 pg. [cited by applicant]
“International Application Serial No. PCT/US2016/069490, International Search Report mailed Mar. 8, 2017”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2016/069490, Written Opinion mailed Mar. 8, 2017”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/040812, International Preliminary Report on Patentability mailed Jan. 16, 2020”, 8 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/040812, International Search Report mailed Sep. 19, 2018”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/040812, Written Opinion mailed Sep. 19, 2018”, 6 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/040588, International Preliminary Report on Patentability mailed Jan. 14, 2021”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/040588, International Search Report mailed Oct. 8, 2019”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/040588, Written Opinion mailed Oct. 8, 2019”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/078066, International Search Report mailed Feb. 7, 2023”, 4 pgs. [cited by applicant]
“International Application Serial No. PCT/US2022/078066, Written Opinion mailed Feb. 7, 2023”, 8 pgs. [cited by applicant]
Beringer, Robert, “The Measurement of Wavelength—Chapter 5 from Technique of Microwave Measurements”, vol. 11 of MIT Radiation Laboratory Series. McGraw-Hill, New York, (1947), 58 pgs. [cited by applicant]
Gopinath, A., et al., “Capacitance Parameters of Discontinuities in Microstriplines”, IEEE Trans. On Microwave Theory and Techniques, vol. MTT-26, No. 10, (Oct. 1978), 831-836. [cited by applicant]
Mahan, Gerald, et al., “Thermoelectric Materials: New Approaches to an Old Problem”, Physics Today, (Mar. 1997), 42-47. [cited by applicant]
Otoole, Ann, et al., “Thermal mitigation of Pseudomonas aeruginosa biofilms”, Biofouling. Sep. 2015; 31(8): 665-675., (2015), 20 pgs. [cited by applicant]
Richardson, Ian P., et al., “Hemodialysis Catheter Heat Transfer for Biofilm Prevention and Treatment”, ASAIO J. 2016; 62(1): 92-99. doi:10.1097/MAT.0000000000000300, (2016). 17 pgs. [cited by applicant]
U.S. Appl. No. 18/664,510, filed May 15, 2024, Frequency And Phase Controlled Transducers And Sensing. [cited by applicant]
U.S. Appl. No. 18/936,660, filed Nov. 4, 2024, Layered Conformable Polymer Dental Or Other Heating Device. [cited by applicant]
“U.S. Appl. No. 17/444,855, Response filed Nov. 1, 2023 to Non Final Office Action mailed Aug. 1, 2023”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 17/444,855, Final Office Action mailed Nov. 29, 2023”, 8 pgs. [cited by applicant]
“European Application Serial No. 19830071.7, Communication Pursuant to Article 94(3) EPC mailed Jan. 23, 2024”, 4 pgs. [cited by applicant]
“U.S. Appl. No. 17/444,855, Response filed Jan. 26, 2024 to Final Office Action mailed Nov. 29, 2023”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 18/334,703, Non Final Office Action mailed Jan. 31, 2024”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/444,855, Notice of Allowance mailed Feb. 16, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/164,087, Non Final Office Action mailed Apr. 3, 2024”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT US2022 078066, International Preliminary Report on Patentability mailed Apr. 25, 2024”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 18/334,703, Response filed Apr. 29, 2024 to Non Final Office Action mailed Jan. 31, 2024”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/444,855, 312 Amendment filed May 15, 2024”, 7 pgs. [cited by applicant]
“European Application Serial No. 19830071.7, Response filed May 17, 2024 to Communication Pursuant to Article 94(3) EPC mailed Jan. 23, 2024”, 19 pgs. [cited by applicant]
“U.S. Appl. No. 17/444,855, PTO Response to Rule 312 Communication mailed Jun. 3, 2024”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 18/334,703, Notice of Allowance mailed Jun. 27, 2024”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 18/164,087, Response filed Jul. 3, 2024 to Non Final Office Action mailed Apr. 3, 2024”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/164,087, Notice of Allowance mailed Sep. 26, 2024”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 18/334,703, Corrected Notice of Allowability mailed Oct. 7, 2024”, 2 pgs. [cited by applicant]
“European Application Serial No. 19830071.7, Invitation pursuant to Article 94(3) and Rule 71(1) EPC mailed Nov. 11, 2024”, 5 pgs. [cited by applicant]
“European Application Serial No. 19830071.7, Response Filed Nov. 25, 2024 to Invitation pursuant to Article 94(3) and Rule 71(1) EPC mailed Nov. 11, 2024”, w Amended Claims, 10 pgs. [cited by applicant]
“U.S. Appl. No. 18/936,660, Preliminary Amendment filed Jan. 14, 2025”, 5 pgs. [cited by applicant]